Stratos Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$217K Sell
740
-482
-39% -$158K 0.01% 568
2025
Q4
$428K Sell
1,222
-36
-3% -$12.2K 0.02% 464
2025
Q3
$406K Buy
+1,258
New +$391K 0.02% 492
2025
Q2
Sell
-504
Closed -$220K 681
2025
Q1
$220K Buy
+504
New +$202K 0.01% 608
2024
Q4
Sell
-871
Closed -$453K 730
2024
Q3
$453K Buy
871
+3
+0.3% +$1.6K 0.02% 518
2024
Q2
$471K Buy
868
+215
+33% +$114K 0.02% 483
2024
Q1
$339K Sell
653
-12
-2% -$5.97K 0.02% 537
2023
Q4
$314K Buy
665
+6
+0.9% +$2.77K 0.02% 547
2023
Q3
$287K Buy
659
+21
+3% +$9.53K 0.02% 539
2023
Q2
$284K Sell
638
-12
-2% -$5.54K 0.02% 520
2023
Q1
$299K Sell
650
-2,212
-77% -$1.05M 0.02% 492
2022
Q4
$1.47M Buy
2,862
+1,915
+202% +$972K 0.12% 228
2022
Q3
$430K Sell
947
-74
-7% -$35.4K 0.05% 375
2022
Q2
$493K Buy
1,021
+48
+5% +$23.7K 0.04% 366
2022
Q1
$478K Buy
973
+257
+36% +$117K 0.04% 381
2021
Q4
$332K Buy
+716
New +$301K 0.02% 449

Other funds holding ELV

Stratos Wealth Advisors's ELV Position: Q1 2026 in Review

Stratos Wealth Advisors reduced its Elevance Health (ELV) stake by 39% in Q1 2026, selling an estimated $158K and leaving 740 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #568.

Stratos Wealth Advisors first reported a position in ELV in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.47M in Q4 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Stratos Wealth Advisors held 740 shares of Elevance Health worth $217K as of Q1 2026.
  • Stratos Wealth Advisors sold 482 Elevance Health shares in Q1 2026, an estimated $158K.
  • Elevance Health made up 0.01% of Stratos Wealth Advisors's portfolio in Q1 2026, its #568 holding.
  • Stratos Wealth Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 16 quarters since.
  • Stratos Wealth Advisors's Elevance Health position peaked at $1.47M in Q4 2022.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.